XBiotech Inc. — Director's Dealing 2019

Jun 28, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2019-06-27

Reporting Person: SIMARD JOHN (Director, Chief Executive Officer, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-27	Stock Option	$7.45	M	300000	Acquired	2029-06-26	Common Stock (300000)	Direct

Footnotes

F1: On June 27, 2019 (the Grant Date) John Simard was granted nonstatutory stock options (the Options) under the Company's 2015 Equity Incentive Plan to purcahse shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The options vest in three equal annual installments commencing as of the first anniversary of the Grant Date with an expiry of ten years from the Grant Date.